Actualités sur Enterprises

Suivre
Abonner Enterprises
Filtre
  • 05.05.2010 – 20:56

    Avanti Mining Inc

    Avanti Mining Announces Dissemination of its CEO TV Interview

    Vancouver, May 5, 2010 (ots/PRNewswire) - (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.) Avanti Mining Inc. is pleased to announce that Craig Nelsen, President & CEO of the Company appeared on a recent episode of resourceINTELLIGENCE TV. Mr. ...

  • 04.05.2010 – 14:00

    Royal dutch shell plc

    Shell Singapore: Meeting Asia's Growing Demand for Petrochemicals

    The Hague, The Netherlands, May 4, 2010 (ots/PRNewswire) - Shell's largest integrated refinery and petrochemicals complex is now fully online. The multi-billion dollar project in Singapore boosts the supply of raw materials for many everyday products and uses ultra-efficient Shell technology. The site is already supplying products to Asian growth markets and to manufacturers in Singapore. It is a cornerstone of ...

  • 04.05.2010 – 10:10

    Wyplay

    WYPLAY Secures 9 Million Euro Third Round Financing

    Marseille, France, May 4, 2010 (ots/PRNewswire) - WYPLAY SAS, a pioneer in the development of the High-Definition Media Center, today announced it has closed a 9 million euro third round of financing. Amundi Private Equity Funds, who led this 3rd round, was joined by A Plus Finance, Elaia Partners and Sofinnova Partners, Wyplay's second round lead investors reflecting their continued confidence in the company. ...

  • 03.05.2010 – 06:03

    EvaluatePharma Ltd

    Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot

    London, May 3, 2010 (ots/PRNewswire) - The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech ...

  • 30.04.2010 – 14:16

    Celtic Pharmaceutical Holdings L.P.

    Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis

    London, New York and Hamilton, Bermuda, April 30, 2010 (ots/PRNewswire) -- Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes(R), for the topical treatment ...